On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral GLP-1R agonist, Rybelsus, ...

The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...

Novo Nordisk has nominated semaglutide for inclusion in the FDA’s Demonstrable Difficulties for Compounding list, which ...

Novo Nordisk CEO Lars Fruergaard Jorgensen has called attention to the complexities of the U.S. healthcare system while ...

Earlier this month, WeightWatchers made the extraordinary announcement that it would be offering its own version of the 'fat ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Despite the benefits of such medicines, like Wegovy, Saxenda and Zepbound, many people who could most benefit from them can’t ...

Coca-Cola CEO James Quincey said an E. coli outbreak linked to its biggest restaurant customer, McDonald's, isn't likely to hurt the beverage company's sales at this stage. The CDC said its ...

A staggering 64% of adults in England are classed as either overweight or obese according to the most recent NHS figures. And ...

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today joined President Joe Biden in Concord, New Hampshire at the New Hampshire Technical Institute for an event on ...